VXRT - Financial Reports List - Vaxart, Inc. - IntrinsicAlpha

Vaxart, Inc. VXRT

Healthcare - Biotechnology - NASDAQ - US

$ 0.3111

-7.55 %

$ 71 M

Market Cap

-0.94

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	367.95%	31.02%	32.00%
Annual Report	FY	10-K	2024-12-31	288.94%	18.82%	20.46%
Quarterly Report	Q3	8-K	2024-09-30	1006.05%	19.08%	18.78%
Quarterly Report	Q2	8-K	2024-06-30	371.35%	26.98%	29.48%
Quarterly Report	Q1	8-K	2024-03-31	684.53%	2.88%	5.87%
Quarterly Report	Q4	8-K	2023-12-31	14650.00%	27.36%	45.73%
Annual Report	FY	10-K	2023-12-31	6796.26%	23.47%	27.26%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	40.63%	39.43%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	23.38%	21.18%
Quarterly Report	Q1	8-K	2023-03-31	227.06%	-0.16%	-3.21%

1